Anorectal manometry: techniques and clinical applications.
J M Jorge, S D Wexner
https://pubmed.ncbi.nlm.nih.gov/8351556Actively Recruiting
Led by State Scientific Centre of Coloproctology, Russian Federation · Updated on 2025-12-05
122
Participants Needed
1
Research Sites
39 weeks
Total Duration
Researchers are evaluating treatment options for patients with chronic anal fissure, a painful rupture of the anal canal mucous membrane lasting over two months and resistant to non-surgical treatments. This condition mainly affects young and able-bodied adults and is caused by spasms of the internal anal sphincter muscle. The study aims to improve treatment outcomes by reducing the frequency and duration of anal sphincter insufficiency after relieving these spasms. Participants will undergo excision of the anal fissure combined with relaxation of the internal sphincter using botulinum toxin type A. The treatment involves injecting 40 units of botulinum toxin into the internal anal sphincter at four specific locations. The study compares this combined approach to similar treatment methods and includes an additional injection of platelet-rich plasma. Patients are randomized into either the main group or control group, both receiving the same interventions. During the trial, researchers will monitor anal sphincter insufficiency over 60 days as the primary outcome. Secondary outcomes include pain intensity, wound healing, sphincter function measurements, temporary disability, and disease relapse, assessed at various intervals up to one year. Participants will be closely observed throughout these periods with clinical evaluations to track treatment effects and safety.
CONDITIONS
Combined Method of Surgical Treatment of Anal Fissure
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 60 days
Participants undergo excision of the anal fissure with injections of botulinum toxin A to relax the internal sphincter.
Approximately 4 visits on days 15, 30, 45, and 60
Total: 1 location
1
SSCCRussia
Moscow, Russia, 123423
Actively Recruiting
E
Evgeny E. Zharkov, MD
E
Ekaterina Yu. Lebedeva
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
J M Jorge, S D Wexner
https://pubmed.ncbi.nlm.nih.gov/8351556J M Jorge, S D Wexner
https://pubmed.ncbi.nlm.nih.gov/8416784Richard L Nelson, Kathryn Thomas, Jenna Morgan...
https://pubmed.ncbi.nlm.nih.gov/22336789J Zetterström, A Mellgren, L L Jensen...
https://pubmed.ncbi.nlm.nih.gov/10528760P Delechenaut, A M Leroi, J Weber...
https://pubmed.ncbi.nlm.nih.gov/1511644H-L Chen, X-B Woo, H-S Wang...
https://pubmed.ncbi.nlm.nih.gov/24500725Neda Valizadeh, Niloufar Yahyapour Jalaly, Mohsen Hassanzadeh...
https://pubmed.ncbi.nlm.nih.gov/22430300Adam Bobkiewicz, Wojciech Francuzik, Lukasz Krokowicz...
https://pubmed.ncbi.nlm.nih.gov/27539490D Gui, E Cassetta, G Anastasio...
https://pubmed.ncbi.nlm.nih.gov/7934496David B Stewart, Wolfgang Gaertner, Sean Glasgow...
https://pubmed.ncbi.nlm.nih.gov/27926552